Myriad Genetics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 298,481, but the productivity of Myriad Genetics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 306 other companies have achieved higher revenue per employee. While Myriad Genetics Inc 's total ranking has deteriorated compared to the previous quarter from 1601 to 2440. Myriad Genetics Inc has 2,700 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MYGN Revenue per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Revenue Change	-10.39 %	2.25 %	0.19 %	-3.98 %	0.61 %
Sales per Employee (TTM) $	298,481	306,667	305,037	304,889	308,037
MYGN's Total Ranking	# 2440	# 1601	# 1828	# 1711	# 1449
Seq. Revenue Change	-4.46 %	-5.31 %	2.93 %	-3.76 %	9.02 %

MYGN Company Profile >> Back to MYGN Efficiency Comparisons >> Compare MYGN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 6
Healthcare Sector	# 307
Overall Market	# 2440

Revenue per Employee Statistics
High	Average	Low
$ 310,148	$ 274,936	$ 213,148
(Dec 31 2024)		(Mar 31 2021)

Financial Statements
Myriad Genetics Inc 's Revenue MRQ	$ 191 Millions	Visit MYGN's Income Statement
Myriad Genetics Inc 's Revenues TTM	$ 806 Millions	Visit MYGN's aggregate revenue growth
What are MYGN's Sales?		Visit MYGN's Sales by Segment

Other Ratios
Myriad Genetics Inc 's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MYGN's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MYGN's Competitors
Revenue per Employee for MYGN's Suppliers
Revenue per Employee for MYGN's Customers

You may also want to know
MYGN's Sales Growth Rates	MYGN's Pe Price to earnings ratio	MYGN's Receivables Turnover Ratio	MYGN's Stock Quote
MYGN's Net Income Growth Rates	MYGN's Ps Price to Sales ratio	MYGN's Sales per Employee	MYGN's Asset Turnover Ratio
MYGN's Net Margin	MYGN's Pb Price to Book ratio	MYGN's Financial Strength Ratios	MYGN's Dividend Payout Ratio

Date modified: 2026-08-13T09:19:57+00:00

Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Jun 30 2026	Number of Employees Jun 30 2026
Iradimed Corporation	520,114.23	$ 86.339 Million	166
Orthofix Medical Inc	519,217.45	$ 833.344 Million	1,605
Lexicon Pharmaceuticals Inc	511,962.96	$ 41.469 Million	81
Perrigo Company Plc	511,604.94	$ 4,144.000 Million	8,100
Butterfly Network Inc	510,727.27	$ 112.360 Million	220
Beone Medicines Ltd	510,686.50	$ 6,128.238 Million	12,000
Elanco Animal Health Incorporated	507,070.71	$ 5,020.000 Million	9,900
Alpha Pro Tech Ltd	505,723.58	$ 62.204 Million	123
Angiodynamics Inc	502,731.01	$ 317.726 Million	632
Zimmer Biomet Holdings Inc	500,517.65	$ 8,508.800 Million	17,000
Biofrontera Inc	499,521.74	$ 45.956 Million	92
Accuray Incorporated	495,467.24	$ 400.833 Million	809
Resmed Inc	495,001.76	$ 5,628.170 Million	11,370
Adaptive Biotechnologies Corporation	493,719.55	$ 308.081 Million	624
Carlsmed Inc	491,787.40	$ 62.457 Million	127
Viatris Inc	491,243.33	$ 14,737.300 Million	30,000
Invivyd Inc	478,401.64	$ 58.365 Million	122
Maravai Lifesciences Holdings Inc	477,898.85	$ 207.886 Million	435
Moderna Inc	474,042.55	$ 2,228.000 Million	4,700
Guardant Health Inc	472,108.94	$ 1,183.105 Million	2,506
Neuropace Inc	471,866.03	$ 98.620 Million	209
Skinhealth Systems Inc	471,817.29	$ 289.224 Million	613
Pelthos Therapeutics Inc	470,695.65	$ 43.304 Million	92
Inogen Inc	470,523.24	$ 354.304 Million	753
Regenxbio Inc	470,301.89	$ 174.482 Million	371
4d Molecular Therapeutics Inc	469,428.57	$ 92.008 Million	196
Stryker Corp	461,375.00	$ 25,837.000 Million	56,000
Atara Biotherapeutics Inc	460,857.14	$ 6.452 Million	14
Glaukos Corp	457,066.73	$ 500.031 Million	1,094
Treace Medical Concepts Inc	456,237.78	$ 205.307 Million	450

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.